These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 1347812)

  • 61. Fertility following ectopic pregnancy with special reference to previous use of an intra-uterine contraceptive device (IUCD).
    Sandvei R; Ulstein M; Wollen AL
    Acta Obstet Gynecol Scand; 1987; 66(2):131-5. PubMed ID: 3618137
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IUD users may have higher risk of contracting PID, studies find; pill may have protective effect.
    Fam Plann Perspect; 1980; 12(4):206-8. PubMed ID: 7439343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device.
    Booth M; Beral V; Guillebaud J
    Br Med J; 1980 Jul; 281(6233):114. PubMed ID: 7427204
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates.
    Morrison CS; Sekadde-Kigondu C; Miller WC; Weiner DH; Sinei SK
    Contraception; 1999 Feb; 59(2):97-106. PubMed ID: 10361624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IUD update: what family planners should know.
    Netw Res Triangle Park N C; 1987; 8(2):1-3. PubMed ID: 12268657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.
    Mohllajee AP; Curtis KM; Peterson HB
    Contraception; 2006 Feb; 73(2):145-53. PubMed ID: 16413845
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Earth, motherhood, and the intrauterine device.
    Eschenbach DA
    Fertil Steril; 1992 Jun; 57(6):1177-9. PubMed ID: 1601138
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion.
    Sinei SK; Schulz KF; Lamptey PR; Grimes DA; Mati JK; Rosenthal SM; Rosenberg MJ; Riara G; Njage PN; Bhullar VB
    Br J Obstet Gynaecol; 1990 May; 97(5):412-9. PubMed ID: 2196934
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reconsidering IUDs.
    Goldberg B
    AVSC News; 1992 Jul; 30(2):7-8. PubMed ID: 12285571
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pelvic colonization with Actinomyces in women using intrauterine contraceptive devices.
    Hager WD; Douglas B; Majmudar B; Naib ZM; Williams OJ; Ramsey C; Thomas J
    Am J Obstet Gynecol; 1979 Nov; 135(5):680-4. PubMed ID: 507119
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
    International Collaborative Post-Marketing Surveillance of Norplant
    Contraception; 2001 Apr; 63(4):167-86. PubMed ID: 11376646
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors.
    Eschenbach DA; Harnisch JP; Holmes KK
    Am J Obstet Gynecol; 1977 Aug; 128(8):838-50. PubMed ID: 407795
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acceptability of IUDs is increasing.
    Finger WR; Barr D
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease.
    Sufrin CB; Postlethwaite D; Armstrong MA; Merchant M; Wendt JM; Steinauer JE
    Obstet Gynecol; 2012 Dec; 120(6):1314-21. PubMed ID: 23168755
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Postpartum insertion of modified intrauterine devices.
    Cole LP; Edelman DA; Potts DM; Wheeler RG; Laufe LE
    J Reprod Med; 1984 Sep; 29(9):677-82. PubMed ID: 6387112
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 79. IUD users in Norway are at low risk for genital C. trachomatis infection.
    Skjeldestad FE; Halvorsen LE; Kahn H; Nordbø SA; Saake K
    Contraception; 1996 Oct; 54(4):209-12. PubMed ID: 8922873
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interception by post-coital IUD insertion.
    Van Santen MR; Haspels AA
    Contracept Deliv Syst; 1981 Jul; 2(3):189-200. PubMed ID: 12278905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.